Encompass Health Corporation $EHC Shares Sold by Strs Ohio

Strs Ohio cut its position in shares of Encompass Health Corporation (NYSE:EHC) by 5.5% during the 2nd quarter, Holdings Channel reports. The firm owned 320,593 shares of the company’s stock after selling 18,700 shares during the period. Strs Ohio’s holdings in Encompass Health were worth $39,314,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of EHC. Amalgamated Bank grew its holdings in Encompass Health by 1.5% during the second quarter. Amalgamated Bank now owns 46,786 shares of the company’s stock worth $5,737,000 after acquiring an additional 671 shares during the period. Keybank National Association OH grew its holdings in Encompass Health by 36.7% during the second quarter. Keybank National Association OH now owns 12,683 shares of the company’s stock worth $1,555,000 after acquiring an additional 3,407 shares during the period. Hantz Financial Services Inc. grew its stake in shares of Encompass Health by 16,653.8% in the 2nd quarter. Hantz Financial Services Inc. now owns 76,900 shares of the company’s stock worth $9,430,000 after purchasing an additional 76,441 shares during the last quarter. Whalen Wealth Management Inc. acquired a new position in shares of Encompass Health in the 2nd quarter worth approximately $644,000. Finally, Jennison Associates LLC grew its stake in shares of Encompass Health by 0.3% in the 2nd quarter. Jennison Associates LLC now owns 793,237 shares of the company’s stock worth $97,275,000 after purchasing an additional 2,128 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Trading Down 6.0%

NYSE EHC opened at $118.04 on Friday. Encompass Health Corporation has a twelve month low of $87.85 and a twelve month high of $127.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The stock has a market cap of $11.89 billion, a price-to-earnings ratio of 22.31, a PEG ratio of 2.20 and a beta of 0.93. The firm’s 50 day moving average price is $124.39 and its two-hundred day moving average price is $118.80.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%.The business had revenue of $136.30 million for the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Equities analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Friday, January 2nd. Encompass Health’s payout ratio is 14.87%.

Insider Buying and Selling

In related news, EVP Patrick William Tuer sold 1,020 shares of the business’s stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the transaction, the executive vice president directly owned 18,846 shares of the company’s stock, valued at approximately $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 2.00% of the company’s stock.

Analysts Set New Price Targets

EHC has been the topic of several recent research reports. KeyCorp lifted their price target on shares of Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 16th. Truist Financial lifted their price target on shares of Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a research report on Thursday, August 14th. Zacks Research upgraded Encompass Health from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 21st. Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Finally, Bank of America lifted their price target on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Two investment analysts have rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the stock. Based on data from MarketBeat, Encompass Health has an average rating of “Buy” and a consensus price target of $142.86.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.